1800-272-662
Shopping Cart 0
countryflagAU
Login

Lifestance Health Group Inc

Healthcare US LFST

6.73USD
-0.18(2.60%)

Last update at 2026-03-10T20:03:00Z

Day Range

6.716.97
LowHigh

52 Week Range

4.749.59
LowHigh

Fundamentals

  • Previous Close 6.91
  • Market Cap2179.04M
  • Volume3052716
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-20.36700M
  • Revenue TTM1103.51M
  • Revenue Per Share TTM2.97
  • Gross Profit TTM 237.02M
  • Diluted EPS TTM-0.48

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -232.73000M -333.10500M - 7.88M
Minority interest - - - -
Net income -215.56400M -307.19700M - 5.67M
Selling general administrative 377.99M 433.73M - 41.06M
Selling and marketing expenses - - - -
Gross profit 237.02M 201.51M - 62.40M
Reconciled depreciation 69.20M 54.14M - 6.09M
Ebit -210.17400M -286.35300M 15.44M 15.24M
Ebitda -141.19400M -233.68600M - 21.34M
Depreciation and amortization 68.98M 52.67M - 6.09M
Non operating income net other -2.62800M -7.84100M - -
Operating income -210.17400M -286.35300M - 15.24M
Other operating expenses 1069.72M 953.86M 16.83M 197.28M
Interest expense 19.93M 38.91M 0.00000M 5.41M
Tax provision -17.16600M -25.90800M - 2.21M
Interest income - - - -
Net interest income -19.92800M -38.91100M - -5.40900M
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense -17.16600M -25.90800M -6.34100M 2.21M
Total revenue 859.54M 667.51M - 212.52M
Total operating expenses 447.19M 487.86M - 47.16M
Cost of revenue 622.52M 466.00M - 150.12M
Total other income expense net -22.55600M -46.75200M - -7.36600M
Discontinued operations - - - -
Net income from continuing ops -215.56400M -307.19700M - 5.67M
Net income applicable to common shares -215.56400M -343.94700M -286.36900M -58.90400M
Preferred stock and other adjustments - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 2233.21M 2173.87M 1927.11M 1569.73M 280.78M
Intangible assets 221.07M 263.29M 300.36M 332.80M 14.95M
Earning assets - - - - -
Other current assets 21.27M 23.73M 4.34M 10.52M 4.81M
Total liab 804.28M 655.15M 382.08M 571.89M 447.13M
Total stockholder equity 1428.93M 1518.72M 1545.03M 997.84M -166.35500M
Deferred long term liab - 38.70M 54.28M - -
Other current liab 146.42M 124.89M 16.09M 62.50M 46.71M
Common stock 3.79M 3.76M 3.74M 1009.51M 0.00300M
Capital stock 3.79M 3.76M 3.74M 1009.51M 0.00300M
Retained earnings -760.84600M -572.63600M -357.07200M -13.12500M -166.35800M
Other liab - 41.48M 107.91M 98.44M 9.90M
Good will 1293.35M 1272.94M 1204.54M 1098.66M 214.61M
Other assets - 6.37M 3.45M 2.65M 1.36M
Cash 78.82M 108.62M 148.03M 18.83M 3.48M
Cash and equivalents - - - - -
Total current liabilities 202.87M 176.00M 116.75M 75.92M 55.01M
Current deferred revenue - - 85.19M - -
Net debt 432.22M 367.87M 9.39M 343.70M 75.83M
Short term debt 49.40M 38.82M 1.32M - -
Short long term debt - 2.35M 1.32M - -
Short long term debt total 511.04M 476.49M 157.42M 362.53M 79.31M
Other stockholder equity 2183.68M 2084.32M 1898.36M 1.45M -
Property plant equipment - 194.19M 152.24M 59.35M 22.43M
Total current assets 225.73M 233.22M 266.52M 76.28M 27.43M
Long term investments - - - - -
Net tangible assets - -17.51000M 40.13M -433.61900M -395.92000M
Short term investments - - - - -
Net receivables 125.64M 100.87M 76.08M 46.93M 19.13M
Long term debt 280.29M 225.08M 157.42M 362.53M 79.31M
Inventory 0.00000M - 38.07M - -
Accounts payable 7.05M 12.29M 14.15M 13.42M 8.30M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 2.30M 3.27M - - -
Additional paid in capital - - - - -
Common stock total equity - 3.76M 3.74M 1009.51M 0.00300M
Preferred stock total equity - - - - -
Retained earnings total equity - -572.63600M -357.07200M - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 7.96M 10.79M 3.45M 2.65M 1.36M
Deferred long term asset charges - - - - -
Non current assets total 2007.48M 1940.65M 1660.59M 1493.45M 253.35M
Capital lease obligations 227.83M 251.41M - - -
Long term debt total - 225.08M 157.42M - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -139.46100M -194.07600M - -73.37500M
Change to liabilities 21.32M 0.62M 0.83M 2.54M
Total cashflows from investing activities -139.46100M -194.07600M -861.16900M -73.37500M
Net borrowings 60.68M -212.59000M 291.41M 55.45M
Total cash from financing activities 47.26M 313.86M 912.27M 48.46M
Change to operating activities -2.94200M 25.73M 11.72M 6.22M
Net income -215.56400M -307.19700M -38.07000M 5.67M
Change in cash -39.40800M 129.20M 42.57M -7.86400M
Begin period cash flow 148.03M 18.83M 3.48M 11.35M
End period cash flow 108.62M 148.03M 3.48M 3.48M
Total cash from operating activities 52.79M 9.42M -8.53300M 17.05M
Issuance of capital stock 0.00000M 549.90M - 0.00000M
Depreciation 69.20M 54.14M 31.05M 6.09M
Other cashflows from investing activities -60.20600M -99.58400M - -
Dividends paid - - - -
Change to inventory - - - -
Change to account receivables -21.66300M -24.21300M -13.30500M -5.75900M
Sale purchase of stock 0.00000M 549.90M - 0.00000M
Other cashflows from financing activities 235.03M 75.34M -32.71800M 48.95M
Change to netincome 191.03M 258.54M -1.72900M 1.58M
Capital expenditures 79.25M 94.49M 38.07M 14.31M
Change receivables -21.66300M -24.21300M - -
Cash flows other operating 6.52M -44.45600M - -
Exchange rate changes - - - -
Cash and cash equivalents changes -39.40800M 129.20M - -
Change in working capital -16.93800M 2.14M - 2.99M
Stock based compensation 187.43M 259.44M - 0.05M
Other non cash items 45.40M 27.85M - 0.48M
Free cash flow -26.46600M -85.07200M - 2.73M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
LFST
Lifestance Health Group Inc		 -0.18 2.60% 6.73 - 151.52 2.18 1.61 2.59 -26.0418
HCA
HCA Holdings Inc		 -7.49 1.37% 537.64 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 0.05 0.36% 14.02 16.87 9.44 0.42 0.78 0.79 5.37
FSNUF
Fresenius SE & Co. KGaA		 - -% 54.35 16.76 9.62 0.42 0.79 0.78 5.31
JDHIY
JD Health International Inc		 - -% 9.08 62.50 35.97 0.30 2.32 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Lifestance Health Group Inc

4800 North Scottsdale Road, Scottsdale, AZ, United States, 85251

Key Executives

Name Title Year Born
Mr. Kenneth Alan Burdick CEO & Chairman 1959
Mr. Danish J. Qureshi Pres & COO 1984
Mr. David Patrick Bourdon Chief Financial Officer & Treasurer 1969
Mr. Warren Gouk Chief Admin. Officer NA
Ms. Monica Prokocki VP of Investor Relations NA
Mr. Ryan Pardo Chief Legal Officer & Sec. 1976
Brooke Matthews Director of PR NA
Ms. Felicia Gorcyca Chief People Officer 1979
Mr. Pablo Pantaleoni Chief Digital Officer 1988
Mr. Kevin Michael Mullins Chief Devel. Officer 1985

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.